A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer

被引：379
|
作者：
Cobleigh, MA
Langmuir, VK
Sledge, GW
Miller, KD
Haney, L
Novotny, WF
Reimann, JD
Vassel, A
机构：
[1] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
[2] Genentech Inc, San Francisco, CA USA
[3] Indiana Univ, Indianapolis, IN 46204 USA
来源：
SEMINARS IN ONCOLOGY | 2003年 / 30卷 / 05期
关键词：
D O I：
10.1053/j.seminoncol.2003.08.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：117 / 124
页数：8
相关论文
共 50 条
  • [41] Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients
    Ramaswamy, Bhuvaneswari
    Elias, Anthony D.
    Kelbick, Nicole T.
    Dodley, Angela
    Morrow, Mark
    Hauger, Marsha
    Allen, Joan
    Rhoades, Chris
    Kendra, Kari
    Chen, Helen X.
    Eckhardt, S. Gail
    Shapiro, Charles L.
    CLINICAL CANCER RESEARCH, 2006, 12 (10) : 3124 - 3129
  • [42] A phase I, dose-escalation study of pomalidomide (CC-4047) in combination with gemcitabine in metastatic pancreas cancer
    Infante, Jeffrey R.
    Jones, Suzanne F.
    Bendell, Johanna C.
    Spigel, David R.
    Yardley, Denise A.
    Weekes, Colin D.
    Messersmith, Wells A.
    Hainsworth, John D.
    Burris, Howard A., III
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (02) : 199 - 205
  • [43] A Phase I Dose-Escalation Study of Carfilzomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis
    Cohen, Adam D.
    Scott, Emma C.
    Liedtke, Michaela
    Kaufman, Jonathan L.
    Landau, Heather
    Vesole, David H.
    Gomes, Christina L.
    Gasparetto, Cristina
    Lentzsch, Suzanne
    Rosenzweig, Michael
    Sanchorawala, Vaishali
    Smith, David D.
    Comenzo, Raymond L.
    Durie, Brian G. M.
    BLOOD, 2014, 124 (21)
  • [44] Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium
    Manish R. Sharma
    Kristen Wroblewski
    Blase N. Polite
    James A. Knost
    James A. Wallace
    Sanjiv Modi
    Bethany G. Sleckman
    David Taber
    Everett E. Vokes
    Walter M. Stadler
    Hedy L. Kindler
    Investigational New Drugs, 2012, 30 : 1211 - 1215
  • [45] Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium
    Sharma, Manish R.
    Wroblewski, Kristen
    Polite, Blase N.
    Knost, James A.
    Wallace, James A.
    Modi, Sanjiv
    Sleckman, Bethany G.
    Taber, David
    Vokes, Everett E.
    Stadler, Walter M.
    Kindler, Hedy L.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (03) : 1211 - 1215
  • [46] A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-D-arginine vasopressin) in breast cancer patients
    Weinberg, Ruth S.
    Grecco, Marcelo O.
    Ferro, Gimena S.
    Seigelshifer, Debora J.
    Perroni, Nancy V.
    Terrier, Francisco J.
    Sanchez-Luceros, Analia
    Maronna, Esteban
    Sanchez-Marull, Ricardo
    Frahm, Isabel
    Guthmann, Marcelo D.
    Di Leo, Daniela
    Spitzer, Eduardo
    Ciccia, Graciela N.
    Garona, Juan
    Pifano, Marina
    Torbidoni, Ana V.
    Gomez, Daniel E.
    Ripoll, Giselle V.
    Gomez, Roberto E.
    Demarco, Ignacio A.
    Alonso, Daniel F.
    SPRINGERPLUS, 2015, 4
  • [47] Phase I/II dose-escalation study of pemetrexed plus irinotecan in patients with advanced colorectal cancer
    Hochster, Howard
    Kettner, Erika
    Kroening, Hendrik
    Becker, Klaus
    Lordick, Florian
    Ramanathan, Ramesh K.
    Macdonald, John
    Hong, Shengyan
    John, William
    Schmoll, Hans-Joachim
    CLINICAL COLORECTAL CANCER, 2005, 5 (04) : 257 - 262
  • [48] N0539 phase II trial of fulvestrant and bevacizumab in patients with metastatic breast cancer previously treated with an aromatase inhibitor: a North Central Cancer Treatment Group (now Alliance) trial
    Tan, W. W.
    Dueck, A. C.
    Flynn, P.
    Steen, P.
    Anderson, D.
    Rowland, K.
    Northfelt, D.
    Perez, E. A.
    ANNALS OF ONCOLOGY, 2013, 24 (10) : 2548 - 2554
  • [49] Pharmacogenomic and Pharmacoproteomic Studies of Cetuximab in Metastatic Colorectal Cancer: Biomarker Analysis of a Phase I Dose-Escalation Study
    Tabernero, Josep
    Cervantes, Andres
    Rivera, Fernando
    Martinelli, Erika
    Rojo, Federico
    von Heydebreck, Anja
    Macarulla, Teresa
    Rodriguez-Braun, Edith
    Vega-Villegas, Maria Eugenia
    Senger, Stefanie
    Ramos, Francisco Javier
    Rosello, Susana
    Celik, Ilhan
    Stroh, Christopher
    Baselga, Jose
    Ciardiello, Fortunato
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) : 1181 - 1189
  • [50] Erlotinib in combination with capecitabine and docetaxel in patients with metastatic breast cancer: A dose-escalation study
    Twelves, Chris
    Trigo, Jose M.
    Jones, Rob
    De Rosa, Flavio
    Rakhit, Ashok
    Fettner, Scott
    Wright, Tonya
    Baselga, Jose
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (03) : 419 - 426
12345